Kidney disease and organ transplantation in methylmalonic acidaemia

Pediatric Transplantation - Tập 23 Số 4 - 2019
Damien Noone1,2, Magdalena Riedl1,2, Paul Atkison3, Yaron Avitzur1,4, Ajay P. Sharma3, Guido Filler3, Komudi Siriwardena5, Chitra Prasad3
1Department of Paediatrics, University of Toronto, Toronto, Ontario Canada
2Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada
3Department of Paediatrics, Western University, London, Ontario, Canada
4Division of Gastroenterology, Hepatology and Nutrition, University of Alberta/Stollery Children's Hospital, Edmonton, Alberta, Canada
5Department of Medical Genetics, University of Alberta, Stollery Children's Hospital, Edmonton, Alberta, Canada

Tóm tắt

AbstractObjectivesMMA is associated with chronic tubulointerstitial nephritis and a progressive decline in GFR. Optimal management of these children is uncertain. Our objectives were to document the pre‐, peri‐, and post‐transplant course of all children with MMA who underwent liver or combined liver‐kidney transplant in our centers.Design and methodsRetrospective chart review of all cases of MMA who underwent organ transplantation over the last 10 years.ResultsFive children with MMA underwent liver transplant (4/5) and combined liver‐kidney transplant (1/5). Three were Mut0 and two had a cobalamin B disorder. Four of five were transplanted between ages 3 and 5 years. Renal dysfunction prior to transplant was seen in 2/5 patients. Post‐transplant (one liver transplant and one combined transplant) renal function improved slightly when using creatinine‐based GFR formula. We noticed in 2 patients a big discrepancy between creatinine‐ and cystatin C‐based GFR calculations. One patient with no renal disease developed renal failure post–liver transplantation. Serum MMA levels have decreased in all to <300 μmol/L. Four patients remain on low protein diet, carnitine, coenzyme Q, and vitamin E post‐transplant.ConclusionsMMA is a complex metabolic disorder. Renal disease can continue to progress post–liver transplant and close follow‐up is warranted. More research is needed to clarify best screening GFR method in patients with MMA. Whether liver transplant alone, continued protein restriction, or the addition of antioxidants post‐transplant can halt the progression of renal disease remains unclear.

Từ khóa


Tài liệu tham khảo

10.1007/s10545-010-9269-1

Manoli I, 1993, GeneReviews® [Internet]

10.1371/journal.pone.0040609

10.1007/s10545-008-0892-z

10.1111/j.1399-3046.2006.00585.x

10.1136/adc.42.225.492

10.1007/BF00444131

10.1203/PDR.0b013e3180a0325f

10.1038/jhg.2013.97

10.1038/gim.2013.42

10.1002/humu.20258

10.1007/s004670050646

10.2215/CJN.10161110

10.1093/ndt/gfn505

10.1007/s00467-011-1838-5

10.1007/s00467-007-0607-y

10.1007/s00467-014-2945-x

10.1007/s00467-012-2245-2

10.1111/j.1744-9987.2011.00974.x

10.1023/A:1010395724012

10.1023/B:BOLI.0000028778.54210.13

10.1111/j.1600-6143.2007.01899.x

10.1111/j.1399-3046.2006.00569.x

10.1016/j.jpeds.2009.07.002

10.1186/1750-1172-6-19

10.1111/j.1399-3046.2011.01607.x

10.1002/lt.22279

10.1016/j.ymgme.2013.05.001

10.1002/lt.25304

10.1016/j.jpeds.2015.01.051

10.1111/j.1399-0012.2010.01168.x

10.1097/TP.0b013e3181b29f0c

10.1007/s00467-016-3324-6

10.1023/A:1005493015489

10.1016/0003-9861(82)90088-1

10.1007/s004670100688

10.1007/s00467-007-0460-z

10.1007/s00467-013-2536-2

10.1007/s00467-017-3880-4

10.1111/petr.12196

10.1186/s13023-014-0130-8

10.3390/jcm6070071

10.1007/s00467-004-1570-5

Ha TS, 2008, Delay of renal progression in methylmalonic acidemia using angiotensin II inhibition: a case report, J Nephrol, 21, 793

10.1053/j.jrn.2006.10.006

10.1177/0115426505020002218

10.1016/j.semnephrol.2005.06.010

10.1007/s00018-005-4463-2

10.1096/fj.08-121848

10.1007/s10545-009-1197-6

10.1007/s10254-002-0003-8

10.1203/PDR.0b013e3181a7c270

10.1016/j.ymgme.2008.06.007

10.1016/j.mrgentox.2010.07.008

10.1073/pnas.1302764110

10.1186/1471-2350-8-64

10.1007/s10545-005-0517-8

10.1111/j.1399-3046.2009.01227.x

10.1111/petr.12804